Cargando…

Utilization of extracorporeal membrane oxygenation for a severe cardiocirculatory dysfunction recipient in liver transplantation: A case report

RATIONALE: Severe cardiac dysfunction or severe pulmonary hypertension is a contraindication of liver transplantation (LT). Extracorporeal membrane oxygenation (ECMO) is an advanced therapy for severe lung and/or cardiocirculatory dysfunction or failure. The application of ECMO to patients during th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xiaodong, Qiu, Wei, Chen, Yuguo, Lv, Guoyue, Fan, Zhongqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155962/
https://www.ncbi.nlm.nih.gov/pubmed/30213015
http://dx.doi.org/10.1097/MD.0000000000012407
_version_ 1783358005878718464
author Sun, Xiaodong
Qiu, Wei
Chen, Yuguo
Lv, Guoyue
Fan, Zhongqi
author_facet Sun, Xiaodong
Qiu, Wei
Chen, Yuguo
Lv, Guoyue
Fan, Zhongqi
author_sort Sun, Xiaodong
collection PubMed
description RATIONALE: Severe cardiac dysfunction or severe pulmonary hypertension is a contraindication of liver transplantation (LT). Extracorporeal membrane oxygenation (ECMO) is an advanced therapy for severe lung and/or cardiocirculatory dysfunction or failure. The application of ECMO to patients during the LT perioperative period may help recipients with severe cardiac disease to maintain the heart function and alleviate the reperfusion syndrome. PATIENT CONCERNS: A female liver recipient complained about weakness for 6 months. DIAGNOSES: The patient was diagnosed as hepatitis B virus (HBV)-related hepatic cirrhosis (MELD 24, Child–Pugh C) with severe mitral regurgitation, severe tricuspid regurgitation, left atrium and left ventricle enlargement, cardiac insufficiency, pulmonary arterial hypertension, and hypoxemia. INTERVENTIONS: The patient underwent LT from a cardiac deceased donor. The surgery was completed by venoarterial ECMO. The femoral vessels cannulation was done after the dissection of the patient's liver and before the venous blocking. Venous cannula reached to the position below renal vein, while arterial cannula reached to common iliac artery. We regulated the ECMO index according to the patient's condition. The dosage of heparin was adjusted on the basis of the activated clotting time. Respiratory support, milrinone, furosemide, and mannitol were used to improve the circulation. The bleeding volume of surgery was 1200 mL. The cardiocirculatory function and other vital signs remained good in the perioperative period. In the first 24 hours after surgery, central venous pressure decreased from 17 to 7 cmH(2)O. Thirty hours after surgery, the ECMO was removed. Eighteen hours later, the recipient did not need respiratory support. OUTCOMES: No complications of transplantation or ECMO were found. LESSONS: It is feasible to utilize ECMO as a cardiocirculatory function support in the LT. ECMO does not increase the risk of hemorrhage. ECMO can play an important role in ensuring the security of the liver recipients in the surgery and in the postoperative period.
format Online
Article
Text
id pubmed-6155962
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-61559622018-11-08 Utilization of extracorporeal membrane oxygenation for a severe cardiocirculatory dysfunction recipient in liver transplantation: A case report Sun, Xiaodong Qiu, Wei Chen, Yuguo Lv, Guoyue Fan, Zhongqi Medicine (Baltimore) Research Article RATIONALE: Severe cardiac dysfunction or severe pulmonary hypertension is a contraindication of liver transplantation (LT). Extracorporeal membrane oxygenation (ECMO) is an advanced therapy for severe lung and/or cardiocirculatory dysfunction or failure. The application of ECMO to patients during the LT perioperative period may help recipients with severe cardiac disease to maintain the heart function and alleviate the reperfusion syndrome. PATIENT CONCERNS: A female liver recipient complained about weakness for 6 months. DIAGNOSES: The patient was diagnosed as hepatitis B virus (HBV)-related hepatic cirrhosis (MELD 24, Child–Pugh C) with severe mitral regurgitation, severe tricuspid regurgitation, left atrium and left ventricle enlargement, cardiac insufficiency, pulmonary arterial hypertension, and hypoxemia. INTERVENTIONS: The patient underwent LT from a cardiac deceased donor. The surgery was completed by venoarterial ECMO. The femoral vessels cannulation was done after the dissection of the patient's liver and before the venous blocking. Venous cannula reached to the position below renal vein, while arterial cannula reached to common iliac artery. We regulated the ECMO index according to the patient's condition. The dosage of heparin was adjusted on the basis of the activated clotting time. Respiratory support, milrinone, furosemide, and mannitol were used to improve the circulation. The bleeding volume of surgery was 1200 mL. The cardiocirculatory function and other vital signs remained good in the perioperative period. In the first 24 hours after surgery, central venous pressure decreased from 17 to 7 cmH(2)O. Thirty hours after surgery, the ECMO was removed. Eighteen hours later, the recipient did not need respiratory support. OUTCOMES: No complications of transplantation or ECMO were found. LESSONS: It is feasible to utilize ECMO as a cardiocirculatory function support in the LT. ECMO does not increase the risk of hemorrhage. ECMO can play an important role in ensuring the security of the liver recipients in the surgery and in the postoperative period. Wolters Kluwer Health 2018-09-14 /pmc/articles/PMC6155962/ /pubmed/30213015 http://dx.doi.org/10.1097/MD.0000000000012407 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle Research Article
Sun, Xiaodong
Qiu, Wei
Chen, Yuguo
Lv, Guoyue
Fan, Zhongqi
Utilization of extracorporeal membrane oxygenation for a severe cardiocirculatory dysfunction recipient in liver transplantation: A case report
title Utilization of extracorporeal membrane oxygenation for a severe cardiocirculatory dysfunction recipient in liver transplantation: A case report
title_full Utilization of extracorporeal membrane oxygenation for a severe cardiocirculatory dysfunction recipient in liver transplantation: A case report
title_fullStr Utilization of extracorporeal membrane oxygenation for a severe cardiocirculatory dysfunction recipient in liver transplantation: A case report
title_full_unstemmed Utilization of extracorporeal membrane oxygenation for a severe cardiocirculatory dysfunction recipient in liver transplantation: A case report
title_short Utilization of extracorporeal membrane oxygenation for a severe cardiocirculatory dysfunction recipient in liver transplantation: A case report
title_sort utilization of extracorporeal membrane oxygenation for a severe cardiocirculatory dysfunction recipient in liver transplantation: a case report
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155962/
https://www.ncbi.nlm.nih.gov/pubmed/30213015
http://dx.doi.org/10.1097/MD.0000000000012407
work_keys_str_mv AT sunxiaodong utilizationofextracorporealmembraneoxygenationforaseverecardiocirculatorydysfunctionrecipientinlivertransplantationacasereport
AT qiuwei utilizationofextracorporealmembraneoxygenationforaseverecardiocirculatorydysfunctionrecipientinlivertransplantationacasereport
AT chenyuguo utilizationofextracorporealmembraneoxygenationforaseverecardiocirculatorydysfunctionrecipientinlivertransplantationacasereport
AT lvguoyue utilizationofextracorporealmembraneoxygenationforaseverecardiocirculatorydysfunctionrecipientinlivertransplantationacasereport
AT fanzhongqi utilizationofextracorporealmembraneoxygenationforaseverecardiocirculatorydysfunctionrecipientinlivertransplantationacasereport